glutathione skin lightening clinical trial randomized for Metabolic Basis and Clinical Evidence

Description

Esler, W

38 In terms of NADKs activities, cNADK phosphorylated at S44, S46, and S48, which may be mediated by the phosphoinositide 3-kinase (PI3K)Akt signaling, has enhanced activity in breast cancer and lung cancer cells, thereby increasing NADPH production

Phase 2 studies indicate significant findings supporting its effectiveness in promoting weight loss and increase muscle mass, making it a unique option among weight loss drugs

10.1515/hsz-2017-0131 10.1515/hsz-2017-0131 [DOI] [PubMed] [Google Scholar] Glorieux C, Calderon PB (2018) Catalase down-regulation in cancer cells exposed to arsenic trioxide is involved in their increased sensitivity to a pro-oxidant treatment